Rosa Mejia

633 total citations
14 papers, 410 citations indexed

About

Rosa Mejia is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Rheumatology. According to data from OpenAlex, Rosa Mejia has authored 14 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Cancer Research and 4 papers in Rheumatology. Recurrent topics in Rosa Mejia's work include Prostate Cancer Diagnosis and Treatment (4 papers), Cancer Genomics and Diagnostics (4 papers) and Prostate Cancer Treatment and Research (4 papers). Rosa Mejia is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (4 papers), Cancer Genomics and Diagnostics (4 papers) and Prostate Cancer Treatment and Research (4 papers). Rosa Mejia collaborates with scholars based in United States, Mexico and Italy. Rosa Mejia's co-authors include Timothy G. Wilson, Bertram Yuh, Nora Ruel, Giacomo Novara, Jeffrey N. Weitzel, Nieves Perdigones, Thomas P. Slavin, Heidi Kosiorek, Barbara A. Pockaj and Carlos Caldas and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The FASEB Journal.

In The Last Decade

Rosa Mejia

14 papers receiving 408 citations

Peers

Countries citing papers authored by Rosa Mejia

Since Specialization

Citations

This map shows the geographic impact of Rosa Mejia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Mejia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Mejia more than expected).

Fields of papers citing papers by Rosa Mejia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa Mejia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Mejia. The network helps show where Rosa Mejia may publish in the future.

Co-authorship network of co-authors of Rosa Mejia

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa Mejia. A scholar is included among the top collaborators of Rosa Mejia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa Mejia. Rosa Mejia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Germline mutations and age at onset of lung adenocarcinoma 2021 ·Cancer ·Karen L. Reckamp, Carolyn E. Behrendt, Thomas P. Slavin, Stacy W. Gray, Danielle Castillo, Marianna Koczywas, Mihaela Cristea, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sharon Sand, Rosa Mejia, (unknown), Ravi Salgia, Jeffrey N. Weitzel	18
2	Development and Pilot Implementation of the Genomic Risk Assessment for Cancer Implementation and Sustainment (GRACIAS) Intervention in Mexico 2021 ·JCO Global Oncology ·Kathleen R. Blazer, Yanin Chávarri-Guerra, Cynthia Villarreal‐Garza, Bita Nehoray, Alejandro Mohar, Adrián Daneri‐Navarro, (unknown), (unknown), Jazmín Arteaga‐Vázquez, Rosa María Álvarez-Gómez, Rosa Mejia, Josef Herzog, Danielle Castillo, María E. Fernández, Jeffrey N. Weitzel	10
3	Clinical conundrums: Developing a strategy for discerning TP53-associated chip and coherent clinical care. 2020 ·Journal of Clinical Oncology ·Jeffrey N. Weitzel, Judy E. Garber, Danielle Castillo, Sharon Sand, Rosa Mejia, (unknown), (unknown), (unknown), (unknown), Jinhui Wang, Xiwei Wu, Josef Herzog, Bita Nehoray, Thomas P. Slavin	1
4	Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer 2019 ·Science Translational Medicine ·Bradon R. McDonald, Tania Contente‐Cuomo, Stephen‐John Sammut, Ahuva Odenheimer-Bergman, Brenda Ernst, Nieves Perdigones, Suet‐Feung Chin, Maria Farooq, Rosa Mejia, Patricia A. Cronin, Karen S. Anderson, Heidi Kosiorek, Donald W. Northfelt, Ann E. McCullough, Bhavika Patel, Jeffrey N. Weitzel, Thomas P. Slavin, Carlos Caldas, Barbara A. Pockaj, Muhammed Murtaza	201
5	Germline mutation profile among Hispanic women with epithelial ovarian cancer (EOC). 2019 ·Journal of Clinical Oncology ·(unknown), Jeffrey N. Weitzel, Kathleen R. Blazer, Thomas P. Slavin, Rosa Mejia, Sharon Sand, Danielle Castillo, Josef Herzog, Cynthia Villarreal‐Garza, Alejandro Mohar, (unknown), (unknown), Christopher R. Hake, Terrence P. Cescon, Kristie Bobolis, (unknown), Ian K. Komenaka, Patricia Rice, (unknown)	1
6	Effect of germline ATM mutations on clonal hematopoiesis. 2019 ·Journal of Clinical Oncology ·Thomas P. Slavin, (unknown), Jeff Longmate, Danielle Castillo, Josef Herzog, Hanjun Qin, Jinhui Wang, Susan L. Neuhausen, Rosa Mejia, (unknown), Milhan Telatar, (unknown), Carolyn B. Hendricks, Christopher R. Hake, Victoria L. Seewaldt, Joseph Geradts, Jeremy M. Stark, Guido Marcucci, Jeffrey N. Weitzel	2
7	Two-stage classifiers that minimize PCA3 and the PSA proteolytic activity testing in the prediction of prostate cancer recurrence after radical prostatectomy. 2017 ·PubMed ·Daniel R. Jeske, (unknown), Timothy G. Wilson, Mark H. Kawachi, (unknown), (unknown), (unknown), Rosa Mejia, (unknown), D.G. Georganopoulou, Steven S. Smith	4
8	Pre-surgical prediction of early biochemical recurrence with expressed prostatic secretion (EPS) biomarkers. 2016 ·Journal of Clinical Oncology ·Jennifer Linehan, Timothy G. Wilson, Mark H. Kawachi, Clayton Lau, (unknown), (unknown), (unknown), Rosa Mejia, Daniel R. Jeske, (unknown), Steven S. Smith	1
9	Complications and outcomes of salvage robot‐assisted radical prostatectomy: a single‐institution experience 2013 ·British Journal of Urology ·Bertram Yuh, Nora Ruel, (unknown), Rosa Mejia, Giacomo Novara, Mark H. Kawachi, Timothy G. Wilson	49
10	Standardized comparison of robot‐assisted limited and extended pelvic lymphadenectomy for prostate cancer 2013 ·British Journal of Urology ·Bertram Yuh, Nora Ruel, Rosa Mejia, Giacomo Novara, Timothy G. Wilson	52
11	Expressed Prostatic Secretion Biomarkers Improve Stratification of NCCN Active Surveillance Candidates: Performance of Secretion Capacity and TMPRSS2:ERG Models 2013 ·The Journal of Urology ·Christopher J. Whelan, Mark H. Kawachi, David Smith, Jennifer Linehan, (unknown), Rosa Mejia, Timothy G. Wilson, Steven S. Smith	21
12	Robotic Extended Pelvic Lymphadenectomy for Intermediate- and High-Risk Prostate Cancer 2012 ·European Urology ·Bertram Yuh, Nora Ruel, Rosa Mejia, (unknown), Timothy G. Wilson	46
13	Vitamin B12 Status and Development of Young Guatemalan Children: Effects of Beef and B12 Supplements 2007 ·The FASEB Journal ·Lindsay H. Allen, Manuel Ramírez‐Zea, (unknown), Rosa Mejia, (unknown), Montague W. Demment, Maureen M. Black	2
14	Cognitive function, motor skills, and behavior of Guatemalan infants with highly prevalent deficient and marginal plasma vitamin B‐12 concentrations 2006 ·The FASEB Journal ·(unknown), Maureen M. Black, Rosa Mejia, Manuel Ramírez‐Zea, (unknown), Lindsay H. Allen	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact